Top Markets
#1 EXOD EXOD +22.08%
#2 Status Status +11.36%
#3 The Bitcoin Bull The Bitcoin Bull +5.66%
#4 Tornado Cash Tornado Cash +5.29%
#5 BCGame Coin BCGame Coin +5.00%
#6 B3 (Base) B3 (Base) +4.43%
#7 MarsCoin MarsCoin +3.79%
#8 Gas Gas +3.76%
#9 Fake World Assets Fake World Assets +3.61%
#10 The Black Bull The Black Bull +3.12%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
Icosavax, Inc. Icosavax, Inc.

Icosavax, Inc.

ICVX
株式のランク #25854
Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing... Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing immunizations against infectious diseases. Leveraging its proprietary virus-like particle (VLP) platform technology, the company primarily focuses its efforts on severe respiratory illnesses. Its developmental portfolio includes several key vaccine candidates: IVX-121, an RSV-targeted vaccine currently undergoing Phase 1/1b clinical trials; IVX-A12, a bivalent candidate designed to target both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV); IVX-241, a candidate specifically designed for hMPV; and IVX-411, a SARS-CoV-2 vaccine based on a receptor binding domain (RBD) sequence antigen, which is also in Phase 1/2 clinical trials. Established in 2017, Icosavax maintains its corporate headquarters in Seattle, Washington.
株価
$15.31
最終同期: 2024-02-29
時価総額
$45.70M
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Icosavax, Inc. (ICVX)

カテゴリー

Healthcare
Icosavax, Inc.（ICVX）の株式分割履歴
Icosavax, Inc.株（シンボル：ICVX）は合計で0回の株式分割を実施しました。
最新の株式分割はAug 21, 2026に行われました。
Aug 21, 2026より前に購入されたICVX株は、現在0ICVX株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US